{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T16:00:00Z","timestamp":1786636800135,"version":"build-2736575974"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Psychiatry"],"published-print":{"date-parts":[[2012]]},"DOI":"10.4103\/0019-5545.104820","type":"journal-article","created":{"date-parts":[[2012,12,18]],"date-time":"2012-12-18T09:47:17Z","timestamp":1355824037000},"page":"337","source":"Crossref","is-referenced-by-count":12,"title":["Safety and efficacy of donepezil hydrochloride in patients with mild to moderate Alzheimer\u2032s disease: Findings of an observational study"],"prefix":"10.4103","volume":"54","author":[{"given":"Suyog","family":"Mehta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Chandersekhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Prasadrao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshman","family":"Dutt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Patkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RD","family":"Nagpal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. S. P.","family":"Raju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KK","family":"Praveen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. S. V.","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Kushwaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyotindra","family":"Nag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Langade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Pawar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0019-5545.104820-1","unstructured":"Medez MF, Cummings JL. Dementia: A Clinical Approach, 3 rd Ed. 1: Dementia Significance, Definition and Epidemiology. Philadelphia: Elseveir; 2006. p. 1-12."},{"key":"key-10.4103\/0019-5545.104820-2","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0733-8619(05)70228-0","article-title":"Neurobehavioral and neuropsychiatric symptoms in Alzheimer\u2032s disease: Characteristics and treatment","author":"Chung","year":"2000","journal-title":"Neurol Clin"},{"key":"key-10.4103\/0019-5545.104820-3","unstructured":"Buckwalter K, Hall G. Alzheimer\u2032s disease. In: McBride AB, Austin JK., Editor. Psychiatric Mental Health Nursing. Philadelphia, Pa: WB Saunders Co; 1996. p. 348-2."},{"key":"key-10.4103\/0019-5545.104820-4","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1021\/jm00081a022","article-title":"\u2032QSAR anaylsis of the substituted indandone and benzylpiperidine rings of a series of indandone-benzylpiperidine inhibitors of acetylcholinesterase","author":"Cardozo","year":"1992","journal-title":"J Med Chem"},{"key":"key-10.4103\/0019-5545.104820-5","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1021\/jm00081a023","article-title":"Conformational analysis and molecular shape comparisons of a series of indanone-benzylpiperidine inhibitors of acetylcholinesterase","author":"Cardozo","year":"1992","journal-title":"J Med Chem"},{"key":"key-10.4103\/0019-5545.104820-6","doi-asserted-by":"crossref","unstructured":"Yamanishi Y, Ogura H, Kosasa T, Araki S, Sawa Y, Yamatsu K. Inhibitory action of E2020, a novel acetylcholinesterase inhibitor, on cholinesterase. Comparison with other inhibitors; in Nagatsu T, Fisher A, Yoshida M (editors). Basic, clinical, and therapeutic aspects of Alzheimer\u2032s and Parkinson\u2032s diseases. New York, Plenum Press; 1990;2:409-3.","DOI":"10.1007\/978-1-4684-5847-3_83"},{"key":"key-10.4103\/0019-5545.104820-7","doi-asserted-by":"crossref","unstructured":"Rogers SL, Yamanishi Y, Yamatsu K. E2020 - The pharmacology of a piperidine cholinesterase inhibitor. In: Becker RE, Giacobini E (editors): Cholinergic basis for Alzheimer therapy. Boston: Birkh\u00e4user; 1991;3:314-20.","DOI":"10.1007\/978-1-4899-6738-1_33"},{"key":"key-10.4103\/0019-5545.104820-8","first-page":"293","article-title":"The efficacy and safety of donepezil in patients with Alzheimer\u2032s disease: Results of a US multicentre, randomized, double-blind, placebo-controlled trial.The Donepezil Study Group","author":"Rogers","year":"1996","journal-title":"Dementia"},{"key":"key-10.4103\/0019-5545.104820-9","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1212\/WNL.50.1.136","article-title":"A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer\u2032s disease","author":"Rogers","year":"1998","journal-title":"Neurology"},{"key":"key-10.4103\/0019-5545.104820-10","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1001\/archinte.158.9.1021","article-title":"Donepezil improves cognition and global function in Alzheimer disease: A 15-week, double-blind, placebo-controlled study.Donepezil Study Group","author":"Rogers","year":"1998","journal-title":"Arch Intern Med"},{"key":"key-10.4103\/0019-5545.104820-11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\"Mini-Mental State\": A practical method for grading the cognitive state of patients for the clinician","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"key-10.4103\/0019-5545.104820-12","first-page":"51","article-title":"Repeatability and validity of a modified Activities of Daily Living (ADL) Index in studies of chronic disability","author":"Sheikh","year":"1979","journal-title":"Int Rehabil Med"},{"key":"key-10.4103\/0019-5545.104820-13","first-page":"298","article-title":"The east Boston Alzheimer\u2032s Disease Registry","author":"Evans","year":"1990","journal-title":"Aging (Milano)"},{"key":"key-10.4103\/0019-5545.104820-14","first-page":"15","article-title":"Epidemiology of Dementia Disorders","author":"Henderson","year":"1990","journal-title":"Adv Neurol"},{"key":"key-10.4103\/0019-5545.104820-15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1212\/WNL.43.1_Part_1.13","article-title":"Education and the prevalence of dementia and Alzheimer\u2032s Disease","author":"Katzman","year":"1993","journal-title":"Neurology"},{"key":"key-10.4103\/0019-5545.104820-16","unstructured":"Canadian Study of Health and Aging: Study Methods & Prevalence of Dementia. CMAJ 1994;150:899-912."},{"key":"key-10.4103\/0019-5545.104820-17","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1212\/WNL.43.3_Part_1.515","article-title":"Incidence of Dementia a probable Alzheimer\u2032s Disease in a general population: The Framingham study","author":"Bachman","year":"1993","journal-title":"Neurology"},{"key":"key-10.4103\/0019-5545.104820-18","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/BF02189530","article-title":"Cross-national comparisons of the occurrence of Alzheimer\u2032s & Vascular Dementias","author":"Jorn","year":"1991","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"key-10.4103\/0019-5545.104820-19","first-page":"293","article-title":"The efficacy and safety of donepezil in patients withAlzheimer\u2032s disease: results of a US multicentre, randomized, double-blind, placebo-controlled trial.The Donepezil Study Group","author":"Rogers","year":"1996","journal-title":"Dementia"},{"key":"key-10.4103\/0019-5545.104820-20","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1212\/WNL.50.1.136","article-title":"A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer\u2032s disease","author":"Rogers","year":"1998","journal-title":"Neurology"},{"key":"key-10.4103\/0019-5545.104820-21","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1001\/archinte.158.9.1021","article-title":"Donepezil improves cognition and global function in Alzheimer disease: A 15-week, double-blind, placebo-controlled study.Donepezil Study Group","author":"Rogers","year":"1998","journal-title":"Arch Intern Med"},{"key":"key-10.4103\/0019-5545.104820-22","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0924-977X(00)00067-5","article-title":"Long-term efficacy and safety of donepezil in the treatment of Alzheimer\u2032s disease: Final analysis of a US multicentre open-label study","author":"Rogers","year":"2000","journal-title":"Eur Neuropsychopharmacol"},{"key":"key-10.4103\/0019-5545.104820-23","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1001\/archneur.57.1.94","article-title":"Donepezil therapy in clinical practice: A randomized crossover study","author":"Greenberg","year":"2000","journal-title":"Arch Neurol"},{"key":"key-10.4103\/0019-5545.104820-24","doi-asserted-by":"crossref","unstructured":"Stephens S, Kalaria R, Kenny RA, Ballard C. Progression of Cognitive Impairments associated with cerebrovascular disease. In In: Paul RH, Cohen R, Ott BR, Salloway S (Eds.), Vascular Dementia - Cerebrovascular Mechanisms and Clinical Management. Totowa, NJ: Humana press 2005;10:145-6.","DOI":"10.1385\/1-59259-824-2:145"},{"key":"key-10.4103\/0019-5545.104820-25","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1185\/030079905X43668","article-title":"Effect of Donepezil in patients with Alzheimer\u2032s Disease previously untreated or treated with memantine or nootropic agents in Germany: An observational study","author":"Klinger","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"key-10.4103\/0019-5545.104820-26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000069988","article-title":"A large Community-Based, Open-label Trial of Donepezil in the Treatment of Alzheimer\u2032s disease","author":"Relkin","year":"2003","journal-title":"Dement Geiatr Cogn Disord"},{"key":"key-10.4103\/0019-5545.104820-27","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2165\/00115677-200210010-00004","article-title":"Management of Alzheimer\u2032s Disease: Defining the Role of Donepezil","author":"Ibbotson","year":"2002","journal-title":"Dis Manage Health Outcomes"},{"key":"key-10.4103\/0019-5545.104820-28","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2165\/00002512-200016030-00005","article-title":"Donepezil: A review of its use in Alzheimer\u2032s disease","author":"Dooley","year":"2000","journal-title":"Drugs Aging"},{"key":"key-10.4103\/0019-5545.104820-29","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0924-977X(00)00067-5","article-title":"Long-term efficacy and safety of donepezil in the treatment of Alzheimer\u2032s disease: Final analysis of a US multicentre open-label study","author":"Rogers","year":"2000","journal-title":"Eur Neuropsychopharmacol"},{"key":"key-10.4103\/0019-5545.104820-30","first-page":"68","article-title":"Alzheimer\u2032s Disease in \u2032Dementia - A Clinical Approach\u2032.3 rd Ed","author":"Mendez","year":"2006","journal-title":"Philadelphia: Elsevier;"},{"key":"key-10.4103\/0019-5545.104820-31","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/gps.1675","article-title":"for TOPS study investigators.\u2032Specific symptomatic changes following donepezil treatment of Alzheimer\u2032s disease: A multicentre, primary care, open-label study","author":"Rockwood","year":"2007","journal-title":"\u2032 Int J Geriatr Psychiatry"},{"key":"key-10.4103\/0019-5545.104820-32","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1212\/WNL.57.3.481","article-title":"A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients","author":"Mohs","year":"2001","journal-title":"Neurology"},{"key":"key-10.4103\/0019-5545.104820-33","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000069988","article-title":"A large Community-Based, Open-label Trial of Donepezil in the Treatment of Alzheimer\u2032s disease","author":"Relkin","year":"2003","journal-title":"Dement Geiatr Cogn Disord"},{"key":"key-10.4103\/0019-5545.104820-34","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1185\/030079905X43668","article-title":"Effect of Donepezil in patients with Alzheimer\u2032s Disease previously untreated or treated with memantine or nootropic agents in Germany:an observational study","author":"Klinger","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"key-10.4103\/0019-5545.104820-35","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000069988","article-title":"A large Community-Based, Open-label Trial of Donepezil in the Treatment of Alzheimer\u2032s disease","author":"Relkin","year":"2003","journal-title":"Dement Geiatr Cogn Disord"},{"key":"key-10.4103\/0019-5545.104820-36","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2165\/00115677-200210010-00004","article-title":"Management of Alzheimer\u2032s Disease: Defining the Role of Donepezil","author":"Ibbotson","year":"2002","journal-title":"Dis Manage Health Outcomes"},{"key":"key-10.4103\/0019-5545.104820-37","unstructured":"ARICEPT\u00ae (Donepezil hydrochloride tablets) . US Package Insert. Teaneck, NJ: Eisai Inc; 2000."},{"key":"key-10.4103\/0019-5545.104820-38","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1185\/030079905X43668","article-title":"Effect of Donepezil in patients with Alzheimer\u2032s Disease previously untreated or treated with memantine or nootropic agents in Germany: An observational study","author":"Klinger","year":"2005","journal-title":"Curr Med Res Opin"}],"container-title":["Indian Journal of Psychiatry"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T15:01:11Z","timestamp":1786633271000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0019-5545.104820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012]]}},"alternative-id":["104820"],"URL":"https:\/\/doi.org\/10.4103\/0019-5545.104820","relation":{},"ISSN":["0019-5545"],"issn-type":[{"value":"0019-5545","type":"print"}],"subject":[],"published":{"date-parts":[[2012]]}}}